Skip to content

A Clinical Study on Improvement of Musculoskeletal Ability in Patients with Dysmotility Syndrome by Chinese Medicine Combined with Exercise Therapy

A Clinical Study on Improvement of Musculoskeletal Ability in Patients with Dysmotility Syndrome by Chinese Medicine Combined with Exercise Therapy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100005355
Enrollment
Unknown
Registered
2021-11-29
Start date
2021-12-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysmotility Syndrome

Interventions

group two:Jianpi prescription chewable tablets
group three:exercise
group one:Jianpi prescription chewable tablets combined with exercise
group four:none

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) 60-75 years old. (2) conforming to the syndrome standard of spleen deficiency syndrome. (3) according with the diagnostic criteria of dyskinesia syndrome. (4) voluntarily participate in this study and sign informed consent.

Exclusion criteria

Exclusion criteria: (1) patients with gastrointestinal dysfunction. (2) the dietary protein intake was lower than that of 1.2g/kg/d. (3) Serum vitamin D level 24.9. (5) patients with severe diseases such as cardiovascular, cerebrovascular, liver, kidney, hematopoiesis, digestive system, etc. (6) patients with cognitive impairment and mental illness. (7) other situations in which the researchers think it is not appropriate to participate in this study.

Design outcomes

Primary

MeasureTime frame
Morbidity rate;SF36 Quality of life scale;

Secondary

MeasureTime frame
Bone mineral density;Sectional CT scan of the third lumbar vertebra;Fracture risk;Sit up for 5 times;Grip strength;Nutritional status;Body composition analysis;Fall risk;Walking speed;TCM syndrome;

Countries

China

Contacts

Public ContactYongfang Zhao
zhao_dingding@126.com13501819578

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026